Emicizumab and Breastfeeding New Clinical Evidence – JTH
Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Simon Alexander Krooss et al., adding:
“Transfer of emicizumab into breast milk in postpartum acquired hemophilia A
Acquired hemophilia A can arise postpartum, and emicizumab is increasingly used for prophylaxis, yet whether it passes into breast milk was unknown.
In a woman who developed AHA four months after delivery, emicizumab reached up to 20 μg/mL in breast milk against a steady-state plasma level of 42 μg/mL.
Anti-FVIII antibodies appeared in plasma but not milk.”
Title: Transfer of emicizumab into breast milk in postpartum acquired hemophilia A
Authors: Simon Alexander Krooss, Tim Halling, Dirk Varnholt, Annika Klingberg, Korbinian Brand, Sonja Werwitzke, Heiner Wedemeyer, Christiane Dobbelstein, Andreas Tiede, Olga Oleshko
Other posts about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Aug 10, 2026, 06:06Mostafa Faisal: What Does High Ferritin Really Mean
-
Aug 10, 2026, 05:45Colin Holburn: Key Laboratory Clues to End Organ Damage
-
Aug 10, 2026, 05:35George Dimitrov: SII and Cancer – What Can This Marker Really Tell Us
-
Aug 10, 2026, 04:53Abdulaziz Elnusiry: Pulmonary Embolism – The Silent Emergency We Need to Talk About
-
Aug 10, 2026, 04:33Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
-
Aug 10, 2026, 04:21Heghine Khachatryan: When Cancer Is Not Enough to Predict VTE Risk
-
Aug 10, 2026, 04:09Ney Carter Borges: How Polyphenols Influence Endothelial Function
-
Aug 10, 2026, 03:54Maria Cherska: One Pill, Better Adherence, Same LDL-C Control
-
Aug 10, 2026, 02:41Edward Lee Carter: Can Anticoagulation Be Safely De-Escalated After AF Ablation?